相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical significance and prognostic value of serum sHER-2/neu levels in patients with solid tumors
C. Papila et al.
MEDICAL ONCOLOGY (2009)
HER2/neu role in breast cancer: from a prognostic foe to a predictive friend
Gianluigi Ferretti et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2007)
Utility of p16(INK4a), CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions
John Liang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
The methylation status and protein expression of CDH1, p16INK4A, and fragile histidine triad in nonsmall cell lung carcinoma -: Epigenetic silencing, clinical features, and prognostic significance
S Nakata et al.
CANCER (2006)
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer
V Esposito et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review
S Singhal et al.
CLINICAL CANCER RESEARCH (2005)
Cytoplasmic expression of c-erbB2 in non-small cell lung cancers
CM Cheng et al.
VIRCHOWS ARCHIV (2005)
The role of HER2/neu expression and trastuzumab in non-small cell lung cancer
FR Hirsch et al.
SEMINARS IN ONCOLOGY (2004)
Electron microscopy evidence that cytoplasmic localization of the p16INK4A nuclear cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact.: A study in non-small cell lung carcinomas
K Evangelou et al.
BIOTECHNIC & HISTOCHEMISTRY (2004)
Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer
WL Ho et al.
CANCER DETECTION AND PREVENTION (2002)
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
K Milde-Langosch et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
N Reinmuth et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
分享论文
